Dr. Jignesh Patel Memorial Symposium

Thursday, October 30, 2025, 4:00 PM - 6:00 PM PT, Cedars-Sinai Harvey Morse Conference Center, Los Angeles, CA


This educational activity is intended for heart failure specialists, general cardiologists, critical care and infectious disease physicians interested in developing their knowledge and understanding of management, treatment options, and monitoring for patients with advanced heart failure and transplantation.

1. Understand and describe the pathophysiology, clinical presentation, diagnostic criteria, methods of risk stratification, and management of patients with cardiac amyloidosis.
2. Understand the risk of infectious complications in post heart transplant recipients and describe best practice for use of vaccines in this population, including risks and benefits.
3. Evaluate the potential of Molecular Diagnostics in the detection of rejection in heart transplant recipients.

In-Person Registration Fee - $0.00

In support of improving patient care, Cedars-Sinai is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement
Cedars-Sinai designates this Live Activity for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician AMA Attendance
Attendance credit will be provided to other healthcare professionals upon the fulfillment of attendance requirements. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.  

AMA PRA Category 1 Credit(s)™ (MD, DO) (2.00 hours), Non-Physician AMA Attendance (2.00 hours)

Mitigation of Relevant Financial Relationships

Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Thursday, October 30, 2025